| P2093 | author name string | Oscar Beloqui | |
| | Carmen Roncal | |
| | Josune Orbe | |
| | Miriam Belzunce | |
| | José A. Páramo | |
| | José A. Rodríguez | |
| P2860 | cites work | Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat | Q72133135 |
| | Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model | Q73265468 |
| | Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta | Q73676314 |
| | Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery | Q73901878 |
| | Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study | Q74637821 |
| | Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques | Q77756578 |
| | High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease | Q28181305 |
| | Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm | Q28245985 |
| | Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases | Q28619201 |
| | Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 |
| | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 |
| | Structure and function of matrix metalloproteinases and TIMPs | Q30014818 |
| | Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms | Q34074796 |
| | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 |
| | Activation of human neutrophil procollagenase by stromelysin 2. | Q34379736 |
| | Biological and clinical relevance of Laminin-5 in cancer | Q34395725 |
| | Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 |
| | Atherosclerosis and cancer: common pathways on the vascular endothelium. | Q34990177 |
| | MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. | Q34997415 |
| | Extracellular matrix remodelling: the role of matrix metalloproteinases | Q35170432 |
| | Surrogate markers for cardiovascular disease: structural markers | Q35822626 |
| | Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. | Q35878888 |
| | Mannheim intima-media thickness consensus. | Q35937841 |
| | Extracellular proteases in atherosclerosis and restenosis. | Q36085385 |
| | C-reactive protein comes of age. | Q36304216 |
| | Atherosclerosis and proteinase activation | Q36352662 |
| | MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. | Q36402867 |
| | Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers | Q36622753 |
| | Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization | Q37594710 |
| | Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin | Q37657212 |
| | Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease | Q40596987 |
| | Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 |
| | Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease | Q44797121 |
| | Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness | Q45158439 |
| | Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors? | Q45200539 |
| | MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices | Q46471271 |
| | Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes | Q47671940 |
| | C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. | Q54610913 |
| | Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease | Q57605907 |
| | Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed | Q60504775 |
| | Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein | Q61687099 |
| | 27 Human stromelysins 1 and 2 | Q72059233 |
| P433 | issue | 3 | |
| P304 | page(s) | 122-128 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Clínica e Investigación en Arteriosclerosis | Q27724679 |
| P1476 | title | Metaloproteasa-10 (estromelisina-2): un nuevo marcador de aterosclerosis subclínica | |
| P478 | volume | 19 | |